IOVA FY 2010 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

IOVAIovance Biotherapeutics, Inc.

$2B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$815,000

Net Income

-$2M

EPS (Diluted)

$-2.46

Cash Flow

Operating Cash Flow

-$620,805

Free Cash Flow

-$620,805

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1M

Total Liabilities

$822,867

Stockholders' Equity

$638,085

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$815,000	-$15,772	-5067.4%
Net Income	-$2M	-$15,772	-10095.3%